CFB
HCAT icon

Cullen/Frost Bankers’s Health Catalyst HCAT Stock Holding History

Cullen/Frost Bankers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60
Closed -$144 – 1464
2025
Q4 		$144 Sell
60
-2,667
-98% -$7.29K ﹤0.01% 1415
2025
Q3 		$7.77K Sell
2,727
-251
-8% -$859 ﹤0.01% 1112
2025
Q2 		$11.2K Buy
2,978
+1,859
+166% +$7.31K ﹤0.01% 1015
2025
Q1 		$5.07K Buy
1,119
+139
+14% +$736 ﹤0.01% 1041
2024
Q4 		$6.93K Buy
980
+113
+13% +$900 ﹤0.01% 938
2024
Q3 		$7.06K Buy
867
+136
+19% +$983 ﹤0.01% 941
2024
Q2 		$4.67K Buy
+731
New +$4.69K ﹤0.01% 962

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cullen/Frost Bankers's HCAT Position: Q1 2026 in Review

Cullen/Frost Bankers sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 60 shares — an estimated $144 sold.

Cullen/Frost Bankers first reported a position in HCAT in Q2 2024 and held it in 7 quarters. The position peaked at $11.2K in Q2 2025. 131 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Cullen/Frost Bankers reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 60 Health Catalyst shares in Q1 2026, an estimated $144.
  • Cullen/Frost Bankers first reported a position in Health Catalyst in Q2 2024 and held it in 7 quarters.
  • Cullen/Frost Bankers's Health Catalyst position peaked at $11.2K in Q2 2025.
  • 131 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.